Abstract

The aim of the work was to study the prognostic usefulness of changes in hemostatic parameters of dogs with parvoviral enteritis.Compared the results of a study of the blood of the dead (n = 4) and the surviving dogs (n = 11) on days 3 and 5 of illness between 2 and 6 months of age among themselves and with the results of blood tests of healthy dogs in the control group (n = 10).On the 3rd day of the disease, we can identify as markers of an unfavorable prognosis a decrease in platelet count to 285,97±14,84х109/L, an increase inMPV to 8,5±1,7 fl and PCT to 0,53±0,02%, an increase in SIAP with ADP to 131,67±9,28% and ristomycin to 127,77±14,71%, a decrease in disaggregation with ADP to1,03±1,03% and ristomycin to 0,08±0,08%, an increase in the amount of fibrinogen to 5,2±0,49 g/l and SFMC to 12,97±1,15 mg/100ml along with a decrease in the activity of antithrombin to 105,3±3,16%.On the 5th day of illness, such parameters as a progressive decrease in platelet count to227±15,64 х109/L are associated with a decrease in the MPV to 5,5±1,2 fl and PCT to 0,21±0,03%, a decrease in SIAP with ADP to 31,67±12,03%, collagen to 15,53±4,26% and ristomycin to14,8±5,6%, reduction of disaggregation with all inductors, lengthening of PT from14,17±0,24 to18,5±2,9 sec., TT from9,07±0,58 to 26,37±1,57 sec. and APTT from18,03±1,54 to 26,37±1,57 sec., increase in SFMC to17,3±1,17mg/100ml, a decrease in fibrinogen to 2,73±0,89g/l and antithrombin activity to 88,63±14,93%.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.